Tool for recommendation of ventilation therapy guided by risk score for acute respirator distress syndrome (ARDS)
US10998095B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2016 |
| Grant date | May 4, 2021 |
| Priority date | — |
| Expiry date | Apr 6, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H70/20
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Disclosed herein are approaches for monitoring a patient in real-time for ARDS development and providing a biomarker-driven ventilation therapy recommendation tool based on the correlation of various therapy patterns and an ARDS biomarker score. When the ARDS biomarker indicates that a patient has a high ARDS risk, the recommendation tool suggests possible therapy routes based on clinical practice. In response to a high score output by the ARDS detection model, the tool outputs a recommendation to initiate a lung protective ventilation strategy (Low Tidal Volume, high Positive End-Expiratory Pressure (PEEP)). A high ARDS score is recognized to be predictive of the appropriateness of such therapy up to several hours before such intervention is typically initiated under current clinical practices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.